Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : Formerly About Advanced Micro Devices -- Ignore unavailable to you. Want to Upgrade?

To: Tenchusatsu who wrote (712656)	5/1/2013 12:49:03 PM
From: i-node	Read Replies (1) \| Respond to of 1577900

>> I'm pretty sure advertising is a huge chunk of the expenses I'm not sure I get the complaints over drug companies spending money on advertising -- as though they, for some unknown reason, should be banned from marketing their products. I'm pretty sure most of these companies' ad budgets are aimed at maximizing profits which entails a delicate balance between spending ad dollars and generating gross revenue. As with any other product. CJ seems to be using the hit-and-run tactic here lately -- stirring up something then quietly disappearing for while. But I'd really like to hear him explain how drug company profits are a bad thing. It is more of the SOS -- corporate profits come at the expense of the poor, which is utter nonsense. The poor buy products in arms-length exchanges like everyone else (except in many cases, they're using OUR arms).

To: Tenchusatsu who wrote (712656)	5/1/2013 5:34:31 PM
From: Bilow	1 Recommendation Read Replies (1) \| Respond to of 1577900

Hi Tenchusatsu; Re pharma costs on R&D... Something I don't trust about these numbers is that they're looking at the over-all figures for the company's spending. That's not right. Instead, the drugs need to be analyzed one at a time. My suspicion is that it will drastically depend on the drug. The drugs that are big hits are the ones that have a lot of advertising expense and low R&D. But those are not the drugs that are at risk of not being developed. It's the drugs with smaller markets that are at risk. And for those, I bet the advertising / R&D costs are completely reversed. If the left gets its (stupid) way, they wouldn't force the drug companies out of existence, they'd just force them to quit doing research in the small market drugs. -- Carl